Vardhana Rao M Vishnu, Maulik Mohua, Gupta Jyotsna, Panchal Yashmin, Juneja Atul, Adhikari Tulsi, Pandey Arvind
Clinical Trials Registry - India, ICMR-National Institute of Medical Statistics, New Delhi, India.
Indian J Pharmacol. 2018 Jul-Aug;50(4):208-211. doi: 10.4103/ijp.IJP_153_18.
The Clinical Trials Registry - India (CTRI), launched over 10 years ago, is a free, searchable online platform for registration of clinical trials being conducted in India and as well as countries which do not have a Primary Registry of their own. The objective of the present article is to appraise the current status and the new developments of CTRI, which registers all types of clinical studies, including postgraduate theses. The CTRI which was until now allowing both prospective and retrospective registration is moving towards only prospective trial registration. From April 1, 2018, only those trials where the first patient enrollment has not yet commenced will be registered. Further, the CTRI is in the process of implementing structured summary results disclosure of all interventional clinical trials in the near future.
印度临床试验注册中心（CTRI）于10多年前成立，是一个免费的、可搜索的在线平台，用于注册在印度以及没有本国主要注册机构的国家开展的临床试验。本文的目的是评估CTRI的现状和新进展，该中心注册所有类型的临床研究，包括研究生论文。CTRI此前允许前瞻性和回顾性注册，目前正朝着仅前瞻性试验注册的方向发展。自2018年4月1日起，仅对首位患者尚未入组的试验进行注册。此外，CTRI正在推进在不久的将来对所有干预性临床试验实施结构化总结结果披露。
